Stock message boards
Market News Video
MNV MNV 10 Oversold Stocks You Need To Know About
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

Cubist Pharmaceuticals Becomes Oversold (CBST)
Thursday, July 17, 4:35 PM ET, by Market News Video Staff

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...

First Week of CBST September 20th Options Trading
Tuesday, July 22, 1:15 PM ET, by Market News Video Staff

Investors in Cubist Pharmaceuticals Inc. (CBST) saw new options begin trading this week, for the ...

UTHR Makes Bullish Cross Above Critical Moving Average
Tuesday, July 29, 11:41 AM ET, by Market News Video Staff

In trading on Tuesday, shares of United Therapeutics Corp (UTHR) crossed above their 200 day ...

United Therapeutics Larger Than S&P 500 Component Graham Holdings
Thursday, July 31, 4:36 PM ET, by Market News Video Staff

In the latest look at stocks ordered by largest market capitalization, Russell 3000 component United ...

Bullish Two Hundred Day Moving Average Cross - CBST
Tuesday, August 26, 11:41 AM ET, by Market News Video Staff

In trading on Tuesday, shares of Cubist Pharmaceuticals Inc. (CBST) crossed above their 200 day ...

  More articles:  1 2 3 4 5 6 7 next »

Bullish Two Hundred Day Moving Average Cross - ANTH

By Market News Video Staff, Friday, October 21, 4:42 PM ET
Play Video: Learn About The 200 DMA

If the video does not load after a few moments, Upgrade to the Latest Flash Player.

In trading on Friday, shares of Anthera Pharmaceuticals Inc. (NASDAQ:ANTH) crossed above their 200 day moving average of $6.28, changing hands as high as $6.89 per share. Anthera Pharmaceuticals Inc. shares are currently trading up about 14.3% on the day. The chart below shows the one year performance of ANTH shares, versus its 200 day moving average:

Anthera Pharmaceuticals Inc. 200 Day Moving Average Chart

Looking at the chart above, ANTH's low point in its 52 week range is $3.65 per share, with $9.08 as the 52 week high point that compares with a last trade of $6.89.

ANTH operates in the Biotechnology sector, among companies like Cubist Pharmaceuticals Inc. (CBST) which is up about 1.1% today, and United Therapeutics Corp (NASDAQ:UTHR) trading up by about 0.1%. Below is a three month price history chart comparing the stock performance of ANTH, versus CBST and UTHR.

ANTH,CBST,UTHR Relative Performance Chart


The ETF Channel Flexible Growth Investment Portfolio is designed to seek growth for investors anywhere and everywhere. The key to the program is our portfolio strategy allows us complete flexibility in terms of asset allocation as there are no predetermined guidelines as to the level of stocks, bonds, cash, regions, countries, sectors, commodities, or even asset classes in the portfolio! In short, this is a completely flexible portfolio designed to follow the performance trail wherever it leads us.

Top Six Most Viewed Stories This Week @ Market News Video:

This Article's Word Cloud:   ANTH   Anthera   CBST   Call   Crossing   Definition   Earnings   Growth   Mortgage   Pharmaceuticals   Price   Rate   Start   Their   Therapeutics   Traded   Trial   UTHR   about   above   allows   asset   average   changing   chart   commodities   currently   designed   flexibility   high   history   level   moving   performance   point   portfolio   program   raquo   regions   sector   sectors   share   shares   that   trading   versus   week   wherever   which   with
About Us - Advertise - Contact Us - Embedding Videos - Licensing Videos - Partners - mRSS / RSS Feed - Terms of Use - Privacy Policy - Video Widget
Home  |  Analyst News  Dividend Report  ETFs  Insider Report  Large Caps  Market Movers  Week Ahead Report  Weekly Market Wrap
MNV MNV Chart Zero Stock Market Game Stock Market Definitions

Bullish Two Hundred Day Moving Average Cross - ANTH | Market News Video | Copyright © 2008 - 2015, All Rights Reserved

Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.